Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | thioredoxin reductase | 0.0096 | 1 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0096 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0055 | 0.4414 | 0.4414 |
Loa Loa (eye worm) | glutathione reductase | 0.0096 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0055 | 0.4414 | 0.5 |
Echinococcus granulosus | calpain A | 0.0061 | 0.5298 | 0.5298 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0096 | 1 | 1 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0043 | 0.2847 | 0.2847 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0055 | 0.4414 | 0.4414 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0055 | 0.4414 | 0.4414 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0061 | 0.5298 | 0.5298 |
Echinococcus multilocularis | calpain A | 0.0061 | 0.5298 | 0.5298 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0055 | 0.4414 | 0.5 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Plasmodium falciparum | glutathione reductase | 0.0096 | 1 | 1 |
Treponema pallidum | NADH oxidase | 0.0055 | 0.4414 | 0.5 |
Brugia malayi | calpain family protein 1 | 0.0059 | 0.4939 | 0.4939 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0055 | 0.4414 | 0.5 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0061 | 0.5298 | 0.5298 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Echinococcus multilocularis | calpain family protein 1, d | 0.0043 | 0.2847 | 0.2847 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0096 | 1 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0055 | 0.4414 | 0.4414 |
Brugia malayi | Thioredoxin reductase | 0.0096 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.4939 | 0.4939 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0059 | 0.4939 | 0.4939 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.004 | 0.2448 | 0.2448 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0096 | 1 | 1 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0061 | 0.5298 | 0.5298 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0096 | 1 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0055 | 0.4414 | 0.5 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0059 | 0.4939 | 0.4939 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.5 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0096 | 1 | 1 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0055 | 0.4414 | 0.5 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0055 | 0.4414 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0055 | 0.4414 | 0.5 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.004 | 0.2448 | 0.2448 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Onchocerca volvulus | 0.0037 | 0.1947 | 0.5 | |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0055 | 0.4414 | 0.4414 |
Plasmodium falciparum | thioredoxin reductase | 0.0096 | 1 | 1 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0061 | 0.5298 | 0.5298 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Plasmodium vivax | glutathione reductase, putative | 0.0096 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0055 | 0.4414 | 0.4414 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1947 | 0.1947 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0055 | 0.4414 | 0.4414 |
Leishmania major | trypanothione reductase | 0.0096 | 1 | 1 |
Brugia malayi | calpain family protein 1 | 0.0059 | 0.4939 | 0.4939 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.2847 | 0.2847 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.404 | 0.404 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0055 | 0.4414 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.0096 | 1 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0055 | 0.4414 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Reversal (functional) | = 0 % | Percent reversal of scopalamine-induced amnesia rat following 10 mg/kg i.p. | ChEMBL. | 8277504 |
Reversal (functional) | = 3 % | Percent reversal of scopalamine-induced amnesia rat following 1.0 mg/kg i.p. | ChEMBL. | 8277504 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.